Tag: Alzheimer’s Disease International
Crisis and Opportunity: Cassava Sciences Still a Strong Buy
“With SAVA, once the pullback has exhausted itself, it’s a strong buy,” we noted on July 29.
Since bottoming out around $65, the stock is...